Stay updated on CBDV vs. Placebo in Children With ASD Clinical Trial
Sign up to get notified when there's something new on the CBDV vs. Placebo in Children With ASD Clinical Trial page.

Latest updates to the CBDV vs. Placebo in Children With ASD Clinical Trial page
- Check2 days agoChange DetectedAdded a Locations section featuring New York as a study site; removed the HHS Vulnerability Disclosure and the New York Locations header.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedPublications section description updated to indicate publications are automatically filled from PubMed, and the page revision version changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check38 days agoChange DetectedThe government funding operating status notice was removed, and core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check52 days agoChange DetectedThe study record shows an administrative update (last update date and QC status) with no changes to study design, eligibility criteria, locations, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check59 days agoChange DetectedThe Study Record Dates section now displays 'Last Update Posted (Estimated)' instead of 'Last Update Posted'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedMajor change: update to v3.2.0 and a prominent notice about government funding impact and operating status; removal of v3.1.0. If users rely on current operating status and versioning, this is significant.SummaryDifference3%

Stay in the know with updates to CBDV vs. Placebo in Children With ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CBDV vs. Placebo in Children With ASD Clinical Trial page.